1 recruiting, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 1, Unknown 1 |
Follow Nonvalvular Atrial Fibrillation: new trials by email Literature Review of Nonvalvular Atrial Fibrillation trials Research Report on Nonvalvular Atrial Fibrillation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure Single Antiplatelet Therapy or No Therapy (Control), Non-Antithrombotic Therapy - Nonvalvular Atrial Fibrillation, Aspirin | Phase 4 | Recruiting | OCEAN-SHD Study Group | 500 | 2025-05-29 | 2025-08-15 |
| AntiCoagulants and COGnition Rivaroxaban 20 MG, Warfarin - Nonvalvular Atrial Fibrillation | Phase 4 | Unknown | University Hospital, Angers | 48 | 2020-02-13 | 2022-07-27 |
Rivaroxaban (1) · Warfarin (1)
OCEAN-SHD Study Group (1) · University Hospital, Angers (1)
France (1) · Japan (1)
2019 (1)